Kalaris Therapeutics Inc (KLRS) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 10K | 10K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.64M | 0 | 547K | 1.09M | 199K | 426K | 846K | 554K | 44K | 33K | 18K |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -10K | -10K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.64M | 0 | -547K | -1.09M | -199K | -426K | -846K | -554K | -44K | -33K | -18K |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | 100% | - | 100% | 100% | -1730.65% | 100% | 35.34% | -97.47% | -352.27% | -1190.91% | -4600% | -2977.78% | -144.44% | -73.68% | 0% |
| Operating Expenses | 11.82M | 10.79M | 12.74M | 12.26M | 10.35M | 37.85M | 4.19M | 2.56M | 3.46M | 43.32M | 47.3M | 42.68M | 39.34M | 42.75M | 44.2M | 42.35M | 55.24M | 45.46M | 37.62M | 30.84M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 4.25M | 3.63M | 3.62M | 3.82M | 4.32M | 1.83M | 976K | 602K | 498K | 12.8M | 12.48M | 12.51M | 12.01M | 12.95M | 13.24M | 14.13M | 14.19M | 12.44M | 11.98M | 10.47M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 7.57M | 7.16M | 9.13M | 8.44M | 6.03M | 36.02M | 3.21M | 1.96M | 2.97M | 30.51M | 34.82M | 30.17M | 27.33M | 29.8M | 30.95M | 28.22M | 41.05M | 33.02M | 25.64M | 20.38M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -11.83M | -10.8M | -12.74M | -12.26M | -10.35M | -37.85M | -4.19M | -2.56M | -3.46M | -46.96M | -47.3M | -43.23M | -40.43M | -42.95M | -44.62M | -43.19M | -55.8M | -45.5M | -37.66M | -30.86M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -14.28% | - | 66.34% | -192.72% | -303.98% | 19.4% | 91.15% | 94.07% | 91.43% | -9.34% | -6.01% | -0.09% | 27.53% | 5.61% | -18.51% | -39.95% | -119.53% | -90.39% | -209.84% | -213.65% |
| EBITDA | -11.83M | -10.79M | -11.89M | -11.35M | -8.75M | -37.27M | -5.15M | -3.33M | -3.43M | -43.32M | -45.27M | -42.68M | -39.34M | -42.75M | -44.2M | -42.35M | -55.24M | -45.46M | -37.62M | -30.84M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -35.19% | - | 68.09% | -120.35% | -162.93% | 13.96% | 88.62% | 92.2% | 91.28% | -1.33% | -2.42% | -0.8% | 28.79% | 5.96% | -17.48% | -37.29% | -117.51% | -90.35% | -210.05% | -214.04% |
| D&A (Non-Cash Add-back) | 0 | 10K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.64M | 0 | 547K | 1.09M | 199K | 426K | 846K | 554K | 44K | 33K | 18K |
| EBIT | -11.83M | -10.8M | -11.89M | -11.35M | -8.75M | -37.27M | -5.15M | -3.33M | -3.43M | -44.27M | -45.27M | -41.18M | -38.55M | -42.07M | -44.49M | -43.86M | -56.93M | -45.51M | -37.59M | -30.92M |
| Net Interest Income | 0 | 0 | 0 | 0 | -1.44M | -815K | -499K | -78K | -39K | 1.52M | 1.52M | 1.32M | 898K | 668K | 162K | 148K | 82K | 253K | 475K | 505K |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.52M | 1.52M | 1.32M | 898K | 668K | 162K | 148K | 82K | 253K | 475K | 505K |
| Interest Expense | 0 | 0 | 0 | 0 | 1.44M | 815K | 499K | 78K | 39K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 977K | 803K | 847K | 906K | 158K | -235K | -1.46M | -844K | -7K | 2.69M | 2.04M | 2.05M | 1.88M | 878K | 135K | -670K | -1.14M | -6K | 67K | -60K |
| Pretax Income | -10.86M | -10M | -11.89M | -11.35M | -10.2M | -38.08M | -5.65M | -3.41M | -3.47M | -44.27M | -45.27M | -41.18M | -38.55M | -42.07M | -44.49M | -43.86M | -56.93M | -45.51M | -37.59M | -30.92M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -415K | 0 | 150K | 0 | 1.01M | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 1.08% | 0% | -0.34% | 0% | -1.77% | 0% | 0% | 0% |
| Net Income | -10.86M | -10M | -11.89M | -11.35M | -10.2M | -38.08M | -5.65M | -3.41M | -3.47M | -44.27M | -45.27M | -41.18M | -38.14M | -42.07M | -44.64M | -43.86M | -57.94M | -45.51M | -37.59M | -30.92M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -6.47% | - | 68.77% | -100.89% | -199.27% | 13.98% | 87.52% | 91.73% | 90.9% | -5.23% | -1.41% | 6.11% | 34.18% | 7.55% | -18.76% | -41.85% | -129.93% | -92.72% | -223.14% | -231.12% |
| Net Income (Continuing) | -10.86M | -10M | -11.89M | -11.35M | -10.2M | -38.08M | -5.65M | -3.41M | -3.47M | -44.27M | -45.27M | -41.18M | -38.14M | -42.07M | -44.64M | -43.86M | -57.94M | -45.51M | -37.59M | -30.92M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.46 | -0.44 | -0.64 | -0.61 | -2.52 | -7.64 | -1.13 | -0.68 | -0.70 | -8.94 | -11.00 | -10.15 | -9.42 | -11.39 | -15.93 | -15.76 | -20.96 | -16.62 | -13.87 | -11.44 |
| EPS Growth % | 81.75% | - | 91.62% | 46.02% | -270.59% | 14.54% | 89.73% | 93.3% | 92.57% | 21.51% | 30.95% | 35.6% | 55.06% | 31.47% | -14.85% | -37.76% | -123.93% | -23.84% | -237.47% | -246.67% |
| EPS (Basic) | -0.46 | -0.44 | -0.64 | -0.61 | -2.52 | -7.64 | -1.13 | -0.68 | -0.70 | -8.94 | -11.00 | -10.15 | -9.42 | -11.39 | -15.93 | -15.76 | -20.96 | -16.62 | -13.87 | -11.44 |
| Diluted Shares Outstanding | 23.72M | 22.9M | 18.7M | 18.7M | 4.05M | 4.98M | 4.98M | 4.98M | 4.96M | 4.95M | 4.11M | 4.06M | 4.05M | 3.69M | 2.8M | 2.78M | 2.76M | 2.74M | 2.71M | 2.7M |
| Basic Shares Outstanding | 23.72M | 22.9M | 18.7M | 18.7M | 4.05M | 4.98M | 4.98M | 4.98M | 4.96M | 4.95M | 4.11M | 4.06M | 4.05M | 3.69M | 2.8M | 2.78M | 2.76M | 2.74M | 2.71M | 2.7M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |